Glaxo wins US approval for drug to treat severe asthma
The genetically engineered antibody is grown in cells from Chinese hamsters and works by reducing levels of white blood cells that contribute to asthma.
Side effects reported in company testing included headache, injection site reactions, back pain, and fatigue.